Anti-Aurora B (phospho S227) antibody [EPR20389]
- RabMAb
- Recombinant
- What is this?
4
(1 Review)
|
(2 Publications)
Rabbit Recombinant Monoclonal Aurora B phospho S227 antibody. Suitable for IP, Dot, WB, ICC/IF and reacts with Human, Synthetic peptide samples. Cited in 2 publications.
View Alternative Names
AIK2, AIM1, AIRK2, ARK2, STK1, STK12, STK5, AURKB, Aurora kinase B, Aurora 1, Aurora- and IPL1-like midbody-associated protein 1, Aurora/IPL1-related kinase 2, STK-1, Serine/threonine-protein kinase 12, Serine/threonine-protein kinase 5, Serine/threonine-protein kinase aurora-B, AIM-1, ARK-2, Aurora-related kinase 2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Aurora B (phospho S227) antibody [EPR20389] (AB210706)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HeLa (human cervix adenocarcinoma epithelial cell) cells labeling Aurora B (phospho S227) with ab210706 at 1/10000 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing midbody staining (arrow) on HeLa cell line.
The nuclear counterstain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-Aurora B (phospho S227) antibody [EPR20389] (AB210706)
Aurora B (phospho S227) was immunoprecipitated from 0.35 mg of HeLa (human epithelial cell line from cervix adenocarcinoma) treated with 100 ng/ml nocodazole for 18 hours whole cell lysate with ab210706 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab210706 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : HeLa treated with 100 ng/ml nocodazole for 18 hours whole cell lysate 10μg (Input).
Lane 2 : ab210706 IP in HeLa treated with 100 ng/ml nocodazole for 18 hours whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab210706 in HeLa treated with 100 ng/ml nocodazole for 18 hours whole cell lysate.
Blocking and dilution buffer : 5% NFDM/TBST.
Exposure time : 30 seconds
All lanes:
Immunoprecipitation - Anti-Aurora B (phospho S227) antibody [EPR20389] (ab210706)
Predicted band size: 39 kDa
false
- WB
Unknown
Western blot - Anti-Aurora B (phospho S227) antibody [EPR20389] (AB210706)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Aurora B (phospho S227) antibody [EPR20389] (ab210706) at 1/1000 dilution
Lane 1:
Untreated HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 2:
HeLa treated with 100 ng/ml nocodazole for 18 hours, whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 39 kDa
true
Exposure time: 3min
- Dot
Unknown
Dot Blot - Anti-Aurora B (phospho S227) antibody [EPR20389] (AB210706)
Dot blot analysis of Aurora B (phospho S227) labeled with ab210706 at 1/1000 dilution.
Lane 1 : Aurora B (phospho S227) peptide.
Lane 2 : Aurora B non-phospho peptide.
Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution was used as secondary antibody.
Blocking/Dilution buffer : 5% NFDM/TBST.
Exposure time : 3 minutes
Related conjugates and formulations (1)
-
Anti-Aurora B (phospho S227) antibody [EPR20389] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Aurora B kinase functions to ensure proper chromosome alignment segregation and cytokinesis during mitosis and meiosis. It phosphorylates various substrates to facilitate processes like correction of kinetochore-microtubule attachments and regulation of the mitotic checkpoint. As a part of the CPC Aurora B acts in coordination with other proteins to control these cellular events ensuring that cells divide accurately and safely.
Pathways
Aurora B integrates into the cell cycle and mitotic pathways operating closely with the spindle assembly checkpoint. It interacts with proteins like CENP-A and CENP-E ensuring error-free chromosome segregation. Aurora B's activity within these pathways is critical for maintaining genomic stability and preventing aneuploidy a condition linked to improper chromosome number.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
EMBO molecular medicine 16:2856-2881 PubMed39394468
2024
Applications
Unspecified application
Species
Unspecified reactive species
Human cell 35:678-693 PubMed35088239
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com